$TRNS
TRANSCAT INC

2024 Q1 Form 10-Q Financial Statement

#000143774924002702 Filed on January 31, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023 Q3
Revenue $70.91M $65.17M $62.80M
YoY Change 14.25% 13.53% 11.28%
Cost Of Revenue $46.88M $44.23M $42.68M
YoY Change 9.23% 7.87% 7.58%
Gross Profit $24.04M $20.94M $20.13M
YoY Change 25.51% 27.66% 20.03%
Gross Profit Margin 33.89% 32.13% 32.04%
Selling, General & Admin $14.83M $16.64M $18.48M
YoY Change 11.55% 25.72% 40.64%
% of Gross Profit 61.71% 79.49% 91.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.703M $3.761M $3.290M
YoY Change 36.54% 33.18% 18.43%
% of Gross Profit 15.41% 17.96% 16.35%
Operating Expenses $14.83M $16.64M $18.48M
YoY Change 11.55% 25.72% 40.64%
Operating Profit $9.204M $4.294M $1.643M
YoY Change 57.2% 35.76% -54.69%
Interest Expense $411.0K $81.00K -$890.0K
YoY Change -152.62% -111.16% 61.82%
% of Operating Profit 4.47% 1.89% -54.17%
Other Income/Expense, Net -$11.00K -$23.00K -$841.0K
YoY Change -95.56% -97.79% 56.61%
Pretax Income $9.604M $4.271M $802.0K
YoY Change 99.01% 101.08% -74.04%
Income Tax $2.714M $923.0K $342.0K
% Of Pretax Income 28.26% 21.61% 42.64%
Net Earnings $6.890M $3.348M $460.0K
YoY Change 88.35% 109.12% -80.48%
Net Earnings / Revenue 9.72% 5.14% 0.73%
Basic Earnings Per Share $0.39 $0.06
Diluted Earnings Per Share $0.77 $0.38 $0.06
COMMON SHARES
Basic Shares Outstanding 8.829M 8.826M 7.688M
Diluted Shares Outstanding 8.752M 7.948M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.18M $35.21M $1.200M
YoY Change 2197.78% 2109.98% 32.01%
Cash & Equivalents $19.65M $35.21M $1.246M
Short-Term Investments $15.53M
Other Short-Term Assets $4.276M $3.295M $3.500M
YoY Change 8.67% -20.43% -20.8%
Inventory $17.42M $16.18M $15.69M
Prepaid Expenses
Receivables $47.78M $43.31M $44.38M
Other Receivables $506.0K $819.0K $335.0K
Total Short-Term Assets $105.2M $98.80M $65.17M
YoY Change 55.56% 62.78% 4.08%
LONG-TERM ASSETS
Property, Plant & Equipment $38.94M $37.22M $35.65M
YoY Change -11.37% 31.37% 28.37%
Goodwill $105.6M $105.7M $106.4M
YoY Change 52.23% 53.58% 60.87%
Intangibles $19.99M $21.46M $23.16M
YoY Change 44.84% 44.57% 55.62%
Long-Term Investments
YoY Change
Other Assets $1.055M $1.055M $1.083M
YoY Change 0.38% 17.88% 34.53%
Total Long-Term Assets $182.4M $182.3M $183.0M
YoY Change 42.33% 42.65% 47.49%
TOTAL ASSETS
Total Short-Term Assets $105.2M $98.80M $65.17M
Total Long-Term Assets $182.4M $182.3M $183.0M
Total Assets $287.6M $281.1M $248.2M
YoY Change 46.9% 49.14% 32.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.50M $11.36M $12.52M
YoY Change -27.56% -17.98% -7.91%
Accrued Expenses $16.74M $13.81M $11.50M
YoY Change 64.09% 53.21% 26.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.339M $2.316M $2.293M
YoY Change 4.05% 4.0% 3.99%
Total Short-Term Liabilities $33.50M $29.35M $28.11M
YoY Change 18.3% 17.02% 12.94%
LONG-TERM LIABILITIES
Long-Term Debt $1.817M $2.411M $51.00M
YoY Change -96.12% -94.86% 4.92%
Other Long-Term Liabilities $2.903M $5.527M $5.477M
YoY Change -79.83% 270.94% 267.09%
Total Long-Term Liabilities $4.720M $7.938M $56.48M
YoY Change -92.3% -83.61% 12.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.50M $29.35M $28.11M
Total Long-Term Liabilities $4.720M $7.938M $56.48M
Total Liabilities $62.38M $62.60M $110.0M
YoY Change -35.1% -32.82% 16.49%
SHAREHOLDERS EQUITY
Retained Earnings $80.07M $74.37M $71.02M
YoY Change 15.78% 13.53% 11.13%
Common Stock $146.0M $144.8M $68.30M
YoY Change 361.19% 368.55% 128.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $225.2M $218.5M $138.3M
YoY Change
Total Liabilities & Shareholders Equity $287.6M $281.1M $248.2M
YoY Change 46.9% 49.14% 32.93%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $6.890M $3.348M $460.0K
YoY Change 88.35% 109.12% -80.48%
Depreciation, Depletion And Amortization $3.703M $3.761M $3.290M
YoY Change 36.54% 33.18% 18.43%
Cash From Operating Activities $5.727M $10.92M $8.430M
YoY Change 92.44% 24.93% 164.1%
INVESTING ACTIVITIES
Capital Expenditures $4.181M $3.659M $2.670M
YoY Change 84.59% 53.93% -212.52%
Acquisitions
YoY Change
Other Investing Activities -$15.46M -$52.00K -$10.01M
YoY Change 1825.28% -98.78%
Cash From Investing Activities -$19.64M -$3.701M -$12.69M
YoY Change 540.19% -44.29% 434.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.677M 26.77M 3.170M
YoY Change -1884.04% -1877.29% -485.64%
NET CHANGE
Cash From Operating Activities 5.727M 10.92M 8.430M
Cash From Investing Activities -19.64M -3.701M -12.69M
Cash From Financing Activities -1.677M 26.77M 3.170M
Net Change In Cash -15.59M 33.98M -1.090M
YoY Change -779650.0% 5650.25% 36233.33%
FREE CASH FLOW
Cash From Operating Activities $5.727M $10.92M $8.430M
Capital Expenditures $4.181M $3.659M $2.670M
Free Cash Flow $1.546M $7.260M $5.760M
YoY Change 117.44% 14.1% 3.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-25
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
3000 usd
CY2022Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
2000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
7000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-4000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
579000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
457000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.5
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.5
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8828515
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8828515
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7562604
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7562604
CY2023Q1 us-gaap Investments
Investments
200000 usd
trns Dilutive Securities Effect Per Share On Earnings
DilutiveSecuritiesEffectPerShareOnEarnings
0.01
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-23
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-03905
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OH
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-0874418
dei Entity Address Address Line1
EntityAddressAddressLine1
35 Vantage Point Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Rochester
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14624
dei City Area Code
CityAreaCode
585
dei Local Phone Number
LocalPhoneNumber
352-7777
dei Security12b Title
Security12bTitle
Common Stock, $0.50 par value
dei Trading Symbol
TradingSymbol
TRNS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8829127
CY2023Q4 us-gaap Revenues
Revenues
65166000 usd
CY2022Q4 us-gaap Revenues
Revenues
57402000 usd
us-gaap Revenues
Revenues
188568000 usd
us-gaap Revenues
Revenues
168502000 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44230000 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41002000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
128797000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
119297000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
20936000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
16400000 usd
us-gaap Gross Profit
GrossProfit
59771000 usd
us-gaap Gross Profit
GrossProfit
49205000 usd
CY2023Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7519000 usd
CY2022Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6595000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20844000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18315000 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9123000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6642000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28350000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20497000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
16642000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
13237000 usd
us-gaap Operating Expenses
OperatingExpenses
49194000 usd
us-gaap Operating Expenses
OperatingExpenses
38812000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
4294000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3163000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
10577000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
10393000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
81000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
731000 usd
us-gaap Interest Expense
InterestExpense
1785000 usd
us-gaap Interest Expense
InterestExpense
1651000 usd
CY2023Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
347000 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
347000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
15000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-289000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-313000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-304000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-96000 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23000 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1039000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1742000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1732000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4271000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2124000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8835000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8661000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
923000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
523000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2078000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1631000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
3348000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1601000 usd
us-gaap Net Income Loss
NetIncomeLoss
6757000 usd
us-gaap Net Income Loss
NetIncomeLoss
7030000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16834000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14876000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1055000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1051000 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8615000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7559000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8060000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7547000
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8752000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7666000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8187000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7644000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
3348000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1601000 usd
us-gaap Net Income Loss
NetIncomeLoss
6757000 usd
us-gaap Net Income Loss
NetIncomeLoss
7030000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
364000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
393000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
488000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-878000 usd
CY2023Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
9000 usd
CY2022Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
21000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-12000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
373000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
401000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
509000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-890000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3721000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2002000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7266000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6140000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35205000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1531000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43307000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44698000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
819000 usd
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
506000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
16178000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
16929000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3295000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3935000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
98804000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
67599000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37222000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29064000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
105700000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
69360000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21459000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13799000 usd
CY2023Q4 us-gaap Assets
Assets
281074000 usd
CY2023Q1 us-gaap Assets
Assets
195749000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11355000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15869000 usd
CY2023Q4 trns Accrued Compensation And Other Liabilities Current
AccruedCompensationAndOtherLiabilitiesCurrent
15683000 usd
CY2023Q1 trns Accrued Compensation And Other Liabilities Current
AccruedCompensationAndOtherLiabilitiesCurrent
10201000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2316000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2248000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
29354000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
28318000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2411000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46869000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10855000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6538000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14457000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12960000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5527000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2247000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
437000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29076000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
782000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-260000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
885000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1434000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
62604000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
96119000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4414000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
3781000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
140382000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
27886000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-691000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1200000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
74365000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
69163000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
218470000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
99630000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
281074000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
195749000 usd
us-gaap Net Income Loss
NetIncomeLoss
6757000 usd
us-gaap Net Income Loss
NetIncomeLoss
7030000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-24000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-62000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
42000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-52000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9841000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8243000 usd
trns Accounts Receivable Credit Loss Expense Reversal And Inventory Writedown
AccountsReceivableCreditLossExpenseReversalAndInventoryWritedown
379000 usd
trns Accounts Receivable Credit Loss Expense Reversal And Inventory Writedown
AccountsReceivableCreditLossExpenseReversalAndInventoryWritedown
174000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3338000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2757000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-3819000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-1850000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3208000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3589000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-728000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1074000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5194000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-424000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3947000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3150000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26889000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13975000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9099000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7149000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12932000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8306000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22031000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15445000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-42713000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
2286000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1678000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1570000 usd
trns Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
75714000 usd
trns Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
503000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33674000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
197000 usd
CY2023Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
137000
CY2022Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
107000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
127000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
97000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1531000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1396000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35205000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1593000 usd
us-gaap Interest Paid Net
InterestPaidNet
1652000 usd
us-gaap Interest Paid Net
InterestPaidNet
1510000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1884000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
957000 usd
us-gaap Stock Issued1
StockIssued1
34769000 usd
us-gaap Stock Issued1
StockIssued1
145000 usd
trns Reclassification Of Property And Equipment To Inventory
ReclassificationOfPropertyAndEquipmentToInventory
737000 usd
trns Reclassification Of Property And Equipment To Inventory
ReclassificationOfPropertyAndEquipmentToInventory
576000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
86176000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
366000 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
437000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
828000 usd
CY2022Q2 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-453000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
3072000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
89552000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
143000 usd
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
-0 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1114000 usd
CY2022Q3 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-838000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2357000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
92328000 usd
CY2022Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
139000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
815000 usd
CY2022Q4 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
401000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1601000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
95284000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
99630000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7030000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
301000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
930000 usd
CY2023Q2 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
482000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2949000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
110720000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
28123000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1946000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1241000 usd
CY2023Q3 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-346000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
460000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
138252000 usd
CY2023Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
80653000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
5323000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1167000 usd
CY2023Q4 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
373000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
3348000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
218470000 usd
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8752000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7666000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates: </b>The preparation of Transcat’s Consolidated Financial Statements in accordance with GAAP requires that the Company make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but <em style="font: inherit;">not</em> limited to, allowance for credit losses and returns, inventory reserves, estimated levels of achievement for performance-based restricted stock units, fair value of stock options, depreciable lives of fixed assets, estimated lives of major catalogs and intangible assets, fair value of the goodwill reporting units, and the valuation of assets acquired, liabilities assumed and consideration transferred in business acquisitions. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the Consolidated Financial Statements <em style="font: inherit;"> may </em>change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. Actual results could differ from those estimates. Such changes and refinements in estimation methodologies are reflected in reported results of operations in the period in which the changes are made and, if material, their effects are disclosed in the Notes to the Consolidated Financial Statements.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;"></p>
CY2023Q4 us-gaap Investments
Investments
200000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7547000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3300000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2800000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
100000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
100000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
300000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.5
CY2023Q4 trns Dilutive Securities Effect Per Share On Earnings
DilutiveSecuritiesEffectPerShareOnEarnings
0.01
trns Dilutive Securities Effect Per Share On Earnings
DilutiveSecuritiesEffectPerShareOnEarnings
0.01
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8615000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7559000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8060000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8187000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7644000
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37000
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
148000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
46000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
163000
CY2023Q1 us-gaap Goodwill
Goodwill
69360000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13799000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
36123000 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
11883000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
-0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4227000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
217000 usd
us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
4000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
105700000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21459000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4056000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3243000 usd
CY2023Q4 trns Accrued Incentive Current
AccruedIncentiveCurrent
3095000 usd
CY2023Q1 trns Accrued Incentive Current
AccruedIncentiveCurrent
2507000 usd
CY2023Q4 trns Current Portion Of Lease Liabilities
CurrentPortionOfLeaseLiabilities
2878000 usd
CY2023Q1 trns Current Portion Of Lease Liabilities
CurrentPortionOfLeaseLiabilities
2333000 usd
CY2023Q4 trns Accrued Acquisition Holdbacks Current
AccruedAcquisitionHoldbacksCurrent
2749000 usd
CY2023Q1 trns Accrued Acquisition Holdbacks Current
AccruedAcquisitionHoldbacksCurrent
252000 usd
CY2023Q4 trns Accrued Contingent Consideration
AccruedContingentConsideration
1029000 usd
CY2023Q1 trns Accrued Contingent Consideration
AccruedContingentConsideration
0 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1876000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1866000 usd
CY2023Q4 trns Accrued Compensation And Other Current Liabilities
AccruedCompensationAndOtherCurrentLiabilities
15683000 usd
CY2023Q1 trns Accrued Compensation And Other Current Liabilities
AccruedCompensationAndOtherCurrentLiabilities
10201000 usd
CY2023Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
1238000 usd
CY2023Q1 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
1266000 usd
CY2023Q4 trns Accrued Acquisition Holdbacks Noncurrent
AccruedAcquisitionHoldbacksNoncurrent
1647000 usd
CY2023Q1 trns Accrued Acquisition Holdbacks Noncurrent
AccruedAcquisitionHoldbacksNoncurrent
0 usd
CY2023Q4 trns Accrued Contingent Consideration Noncurrent
AccruedContingentConsiderationNoncurrent
2402000 usd
CY2023Q1 trns Accrued Contingent Consideration Noncurrent
AccruedContingentConsiderationNoncurrent
0 usd
CY2023Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
240000 usd
CY2023Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
168000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5527000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1434000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
700000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
500000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
217000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
56.25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
37000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
93.18
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
24.3
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
68.13
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
245000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
62.06
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11180000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
82000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
41.17
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
4984000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
300000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000 usd
CY2023Q4 us-gaap Revenues
Revenues
65166000 usd
CY2022Q4 us-gaap Revenues
Revenues
57402000 usd
us-gaap Revenues
Revenues
188568000 usd
us-gaap Revenues
Revenues
168502000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
20936000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
16400000 usd
us-gaap Gross Profit
GrossProfit
59771000 usd
us-gaap Gross Profit
GrossProfit
49205000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
16642000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
13237000 usd
us-gaap Operating Expenses
OperatingExpenses
49194000 usd
us-gaap Operating Expenses
OperatingExpenses
38812000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
4294000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3163000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
10577000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
10393000 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23000 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1039000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1742000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1732000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
923000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
523000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2078000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1631000 usd
CY2023Q4 us-gaap Other General Expense
OtherGeneralExpense
946000 usd
CY2022Q4 us-gaap Other General Expense
OtherGeneralExpense
1562000 usd
us-gaap Other General Expense
OtherGeneralExpense
3820000 usd
us-gaap Other General Expense
OtherGeneralExpense
3363000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
3348000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1601000 usd
us-gaap Net Income Loss
NetIncomeLoss
6757000 usd
us-gaap Net Income Loss
NetIncomeLoss
7030000 usd
CY2023Q4 us-gaap Revenues
Revenues
65166000 usd
CY2022Q4 us-gaap Revenues
Revenues
57402000 usd
us-gaap Revenues
Revenues
188568000 usd
us-gaap Revenues
Revenues
168502000 usd
CY2023Q4 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
65166000 usd
CY2022Q4 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
62868000 usd
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
192613000 usd
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
186276000 usd
CY2023Q4 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
3348000 usd
CY2022Q4 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
1383000 usd
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
6548000 usd
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
5801000 usd
CY2023Q4 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.39
CY2022Q4 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.18
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.81
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.77
CY2023Q4 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.38
CY2022Q4 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.18
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.8
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.76
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
80500000 usd
CY2023Q3 trns Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
75200000 usd

Files In Submission

Name View Source Status
trns-20231223_lab.xml Edgar Link unprocessable
trns-20231223_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
trns-20231223_cal.xml Edgar Link unprocessable
trns-20231223_pre.xml Edgar Link unprocessable
0001437749-24-002702-index-headers.html Edgar Link pending
0001437749-24-002702-index.html Edgar Link pending
0001437749-24-002702.txt Edgar Link pending
0001437749-24-002702-xbrl.zip Edgar Link pending
ex_611578.htm Edgar Link pending
ex_611579.htm Edgar Link pending
ex_611580.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trns-20231223.xsd Edgar Link pending
trns20240103_10q.htm Edgar Link pending
trns20240103_10q_htm.xml Edgar Link completed